Paracetamol for low back pain: the state of the research field

References

• McCrae JC, Morrison EE, MacIntyre IM, et al. Long-term adverse effects of paracetamol – a review. Br J Clin Pharmacol. 2018;84:2218–2230.
   PubMed Web of Science ®Google Scholar
• Morse HN. Ueber eine neue darstellungsmethode der acetylamidophenole. Ber Dtsch Chem Ges. 1878;11:232–233.
   Google Scholar
• Von Mering J. Beitrage zur kenntniss der antipyretica. Therap Monatsch. 1983;7:577–587.
   Google Scholar
• Brodie BB, Axelrod J. The fate of acetanilide in man. J Pharmacol Exp Ther. 1948;94(1):577–587.
   Web of Science ®Google Scholar
• Brodie BB, Axelrod J. The estimation of acetanilide and its metabolic products, aniline, N-acetyl p-ami-nophenol and p-amini-phenol, free and total conjugated, in biological fluids and tissues. J Pharmacol Exp Ther. 1948;94(1):22–28.
   PubMed Web of Science ®Google Scholar
• Flinn FB, Brodie BB. The effect on the pain threshold of N-acetyl p-aminophenol, a product derived in the body from acetanilide. J Pharmacol Exp Ther. 1948;94(1):76.
   PubMed Web of Science ®Google Scholar
• Moore RA, Moore N. Paracetamol and pain: the kiloton problem. Eur J Hosp Pharm Sci Pract. 2016;23(4):187–188.
   PubMedGoogle Scholar
• Prescott LF. Paracetamol: past, present and future. Am J Ther. 2000;7:143–147.
   PubMed Web of Science ®Google Scholar
• Davies NM, Good RL, Roupe KA. et al. Cyclooxygenase_3: axiom, dogma, anomaly, enigma or splice error? — not as easy as 1, 2, 3. J Pharm Pharmaceut Sci. 2004;7(2):217–226.
   PubMed Web of Science ®Google Scholar
• Graham GG, Scott KF. Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology. 2003;11(4–6):401–413.
   PubMedGoogle Scholar
• Serhan CN. Lipoxins and aspirin triggered 15 epilipoxin biosynthesis: an update and role in antiinflammation and proresolution. Prostaglandins Other Lipid Mediat. 2002;68—69:433–455.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Hong S, Gronert K, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002;196(8):1025–1037. .
   PubMed Web of Science ®Google Scholar
• Klinger-Gratz PP, Ralvenius WT, Neumann E, et al. Acetaminophen relieves inflammatory pain through CB1 cannabinoid receptors in the rostral ventromedial medulla. J Neurosci. 2018 Jan 10;38(2):322–334.
   PubMed Web of Science ®Google Scholar
• De Coster O, Forget P, De Mey J, et al. Identification of the cerebral effects of paracetamol in healthy subjects: an fMRI study. Br J Pain. 2020;14(1):23–30.
   PubMed Web of Science ®Google Scholar
• Hartvigsen J, MJ H, Kongsted A, et al., What low back pain is and why we need to pay attention. Lancet. 391(10137): 2356‐2367. 2018. .
   PubMed Web of Science ®Google Scholar
• Foster NE, Anema JR, Cherkin D, et al., Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 391(10137): 2368‐2383. 2018. .
   Web of Science ®Google Scholar
• Peul WC, van Houwelingen HC, van den Hout WB, et al. Surgery versus prolonged conservative treatment for sciatica. N Engl J Med. 2007;356(22):2245–2256. .
   PubMed Web of Science ®Google Scholar
• Vogt MT, Kwoh CK, Cope DK, et al. Analgesic usage for low back pain: impact on healthcare costs and services use. Spine (Phila Pa 1976). 2005;30(9):1075–1081. .
   PubMed Web of Science ®Google Scholar
• Enthoven WT, Scheele J, Bierma-Zeinstra SM, et al. Analgesic use in older adults with back pain: the BACE study. Pain Med. 2014 Oct;15(10):1704–1714.
   PubMed Web of Science ®Google Scholar
• Mathieson S, Valenti L, Maher CG, et al. Worsening trends in analgesics recommended for spinal pain in primary care. Eur Spine J. 2018;27(5):1136–1145. .
   PubMed Web of Science ®Google Scholar
• Rodondi PY, Dubois J, Bill AS, et al. Primary care physicians’ attitude and reported prescribing behavior for chronic low back pain: an exploratory cross-sectional study. PLoS One. 2018 [Published 2018 Sep 27];13(9):e0204613. .
   PubMed Web of Science ®Google Scholar
• Schreijenberg M, Koes BW, Lin CC. Guideline recommendations on the pharmacological management of non-specific low back pain in primary care - is there a need to change? Expert Rev Clin Pharmacol. 2019;12(2):145‐157.
   PubMed Web of Science ®Google Scholar
• Saragiotto BT, Machado GC, Ferreira ML, et al. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016 Jun 7;6:CD012230.
   Google Scholar
• Williams CM, Maher CG, Latimer J, et al., Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 384(9954): 1586‐1596. 2014. .
   Web of Science ®Google Scholar
• Nadler SF, Steiner DJ, Erasala GN, et al. Continuous low-level heat wrap therapy provides more efficacy than Ibuprofen and acetaminophen for acute low back pain. Spine (Phila Pa 1976). 2002;27(10):1012‐1017. .
   PubMed Web of Science ®Google Scholar
• Wetzel L, Zadrazil M, Paternostro-Sluga T, et al. Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study [retracted in: eur J Anaesthesiol. Apr;32(4):287]. Eur J Anaesthesiol. 2014;31(1):35‐40. .
   PubMed Web of Science ®Google Scholar
• Friedman BW, Irizarry E, Chertoff A, et al. Ibuprofen plus acetaminophen versus ibuprofen alone for acute low back pain: an emergency department-based randomized study. Acad Emerg Med. 2020;27(3):229‐235.
   Web of Science ®Google Scholar
• Roelofs PD, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008 [Published 2008 Jan 23];1:CD000396.
   Google Scholar
• van der Gaag WH, Roelofs PD, Enthoven WT, et al. Non-steroidal anti-inflammatory drugs for acute low back pain. Cochrane Database Syst Rev. 2020 [Published 2020 Apr 16];4(4):CD013581.
   PubMedGoogle Scholar
• Enthoven WT, Roelofs PD, Deyo RA, et al. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016 [Published 2016 Feb 10];2(2):CD012087.
   PubMedGoogle Scholar
• Enthoven WTM, Roelofs PD, Koes BW. NSAIDs for Chronic Low Back Pain. JAMA. 2017 Jun 13;317(22):2327–2328.
   PubMed Web of Science ®Google Scholar
• Rasmussen-Barr E, Held U, Grooten WJ, et al. Nonsteroidal Anti-inflammatory Drugs for Sciatica: an Updated Cochrane Review. Spine (Phila Pa 1976). 2017;42(8):586‐594. .
   PubMed Web of Science ®Google Scholar
• Rasmussen-Barr E, Held U, Grooten WJ, et al. Non-steroidal anti-inflammatory drugs for sciatica. Cochrane Database Syst Rev. 2016 [Published 2016 Oct 15];10(10):CD012382.
   PubMedGoogle Scholar
• Wiesel SW, Cuckler JM, Deluca F, et al. Acute low-back pain. An objective analysis of conservative therapy. Spine (Phila Pa 1976). 1980;5(4):324‐330.
   PubMed Web of Science ®Google Scholar
• Miki K, Ikemoto T, Hayashi K, et al. Randomized open-label [corrected] non-inferiority trial of acetaminophen or loxoprofen for patients with acute low back pain [published correction appears in J Orthop Sci. 2019 Jan;24(1):192]. J Orthop Sci. 2018;23(3):483‐487.
   PubMed Web of Science ®Google Scholar
• Hickey RF. Chronic low back pain: a comparison of diflunisal with paracetamol. N Z Med J. 1982;95(707):312‐314.
   PubMed Web of Science ®Google Scholar
• Koes BW, van Tulder M, Lin CW, et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010 Dec;19(12):2075–2094. .
   PubMed Web of Science ®Google Scholar
• Schreijenberg M, Luijsterburg PAJ, Van Trier YDM, et al. Discontinuation of the PACE Plus trial: problems in patient recruitment in general practice. BMC Musculoskelet Disord. 2018 [Published 2018 May 14];19(1):146. .
   PubMedGoogle Scholar
• Schreijenberg M, Luijsterburg PA, Van Trier YD, et al. Efficacy of paracetamol, diclofenac and advice for acute low back pain in general practice: design of a randomized controlled trial (PACE Plus). BMC Musculoskelet Disord. 2017 [Published 2017 Feb 1];18(1):56. .
   PubMedGoogle Scholar
• Schreijenberg M, Chiarotto A, Mauff KAL, et al. Inferential reproduction analysis demonstrated that “paracetamol for acute low back pain” trial conclusions were reproducible. J Clin Epidemiol. 2020;121:45‐54.
   PubMed Web of Science ®Google Scholar
• Bier JD, Kamper SJ, Verhagen AP, et al. Patient nonadherence to guideline-recommended care in acute low back pain. Arch Phys Med Rehabil. 2017;98(12):2416‐2421.
   PubMed Web of Science ®Google Scholar
• Schreijenberg M, Lin CC, Mclachlan AJ, et al. Paracetamol is ineffective for acute low back pain even for patients who comply with treatment: complier average causal effect analysis of a randomized controlled trial. Pain. 2019;160(12):2848‐2854.
   PubMed Web of Science ®Google Scholar
• Roberts E, Delgado Nunes V, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552‐559.
   Web of Science ®Google Scholar
• Barkin RL. Pharmacist’s evolving role in the nonopioid, over-the-counter, analgesic selection process. Am J Ther. 2015;22:423–430.
   PubMed Web of Science ®Google Scholar
• Oliveira CB, Maher CG, Pinto RZ, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791‐2803.
   Web of Science ®Google Scholar
• Koes BW, Backes D, Bindels PJE. Pharmacotherapy for chronic non-specific low back pain: current and future options. Expert Opin Pharmacother. 2018;19(6):537‐545.
   PubMed Web of Science ®Google Scholar
• Carvalho C, Caetano JM, Cunha L, et al. Open-label placebo treatment in chronic low back pain: a randomized controlled trial [published correction appears in Pain. 2017 Feb;158(2):365]. Pain. 2016;157(12):2766‐2772.
   PubMed Web of Science ®Google Scholar
• Kleine-Borgmann J, Schmidt K, Hellmann A, et al. Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial. Pain. 2019;160(12):2891‐2897.
   Web of Science ®Google Scholar
• Enck P, Klosterhalfen S, Weimer K, et al. The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1889–1895.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, McLean RM, et al. Clinical guidelines committee of the American college of physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American college of physicians. Ann Intern Med. 2017;166(7):514‐530.
   Web of Science ®Google Scholar